Your both right!
Cantrixil and Anisina both work best with other drugs. It's all in the latest scientific presentations/papers by the scientists. Stuff that this preclinical drug company thinks it does not have to inform the market about through an ASX announcement because it is preclinical work and not relating to clinical trials.
- Forums
- ASX - By Stock
- KZA
- ALP funding for Ovarian cancer research
ALP funding for Ovarian cancer research, page-8
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online